{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:05:49Z","timestamp":1783526749539,"version":"3.55.0"},"reference-count":161,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Scutellarin (SC), a natural flavonoid, has been expansively employed in treating innumerable inflammation-related diseases due to its antitumor, antiinflammatory, anticancer, and antioxidant potential. Scutellarin can inhibit significant inflammatory cell signaling pathways, comprisingPI3K\/Akt, NF-\u03baB, and MAPK, and while activating antioxidant-related pathways such as Nrf2 and ARE. Numerous reviews have outlined scutellarin\u2019s pharmacological effects and associated mechanisms in inflammation-related diseases. Several studies have elucidated the mechanisms of anticancer activity by inhibiting various signaling pathways; however, to our knowledge, none of the reviews have distinguished the anticancer potential of scutellarin based on different human cancer types. Our review outlined detailed insights about the anticancer potential of scutellarin based on cancer type in the human body. Furthermore, we have also outlined formulations, combinatorial therapies, and comprehensive mechanistic research to deliver enhanced and effective treatment options for cancer patients. This study will provide thorough and detailed insights into scutellarin, supporting its development as a promising candidate for cancer treatment.<\/jats:p>","DOI":"10.3389\/fphar.2025.1579609","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T18:01:12Z","timestamp":1743098472000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Recent advancement in the anticancer efficacy of the natural flavonoid scutellarin: a comprehensive review"],"prefix":"10.3389","volume":"16","author":[{"given":"Deena","family":"Elsori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratibha","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshi","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasir","family":"Vadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Roopashree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Lakshmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laxmidhar","family":"Maharana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Nathiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safia","family":"Obaidur Rab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.3390\/molecules26051315","article-title":"Potential therapeutic targets of quercetin, a plant flavonol, and its role in the therapy of various types of cancer through the modulation of various cell signaling pathways","volume":"26","author":"Almatroodi","year":"2021","journal-title":"Molecules"},{"key":"B2","doi-asserted-by":"publisher","first-page":"100422","DOI":"10.1016\/j.ctarc.2021.100422","article-title":"Tumor angiogenesis: current challenges and therapeutic opportunities","volume":"28","author":"Al-Ostoot","year":"2021","journal-title":"Cancer Treat. Res. Commun."},{"key":"B3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3892\/mco.2021.2433","article-title":"General insight into cancer: an overview of colorectal cancer (Review)","volume":"15","author":"Alzahrani","year":"2021","journal-title":"Mol. Clin. Oncol."},{"key":"B4","first-page":"19","article-title":"Genetic alterations in colorectal cancer","volume":"5","author":"Armaghany","year":"2012","journal-title":"Gastrointest. cancer Res. GCR"},{"key":"B5","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s12032-022-01817-6","article-title":"The role of HER2 alterations in clinicopathological and molecular characteristics of breast cancer and HER2-targeted therapies: a comprehensive review","volume":"39","author":"Asgari-Karchekani","year":"2022","journal-title":"Med. Oncol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2147\/JHC.S61146","article-title":"Hepatocellular carcinoma: a review","volume":"3","author":"Balogh","year":"2016","journal-title":"J. Hepatocell. carcinoma"},{"key":"B7","first-page":"1050","article-title":"Scutellarin exerts anticancer effects on human leukemia cells via induction of Sub-G1 cell cycle arrest, apoptosis and also inhibits migration and invasion by targeting Raf\/MEK\/ERK signalling pathway","volume":"25","author":"Bao","year":"2020","journal-title":"J. B.U.ON, official J. Balkan Union Oncol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.3390\/nu16152550","article-title":"Polyphenols: secondary metabolites with a biological impression","volume":"16","author":"Bolat","year":"2024","journal-title":"Nutrients"},{"key":"B9","volume-title":"Molecular regulation of intussusceptive angiogenesis by ephrinB2\/EphB4 signaling and its therapeutic potential (Doctoral dissertation, University_of_Basel)","author":"Brki\u0107","year":"2017"},{"key":"B10","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1080\/03639040500216220","article-title":"The physicochemical characteristics of freeze-dried scutellarin-cyclodextrin tetracomponent complexes","volume":"31","author":"Cao","year":"2005","journal-title":"Drug Dev. industrial Pharm."},{"key":"B11","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/1759-7714.12962","article-title":"Scutellarin suppresses proliferation and promotes apoptosis in A549 lung adenocarcinoma cells via AKT\/mTOR\/4EBP1 and STAT3 pathways","volume":"10","author":"Cao","year":"2019","journal-title":"Thorac. cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"10435","DOI":"10.2147\/IJN.S265659","article-title":"Nose-to-brain delivery by nanosuspensions-based in situ gel for breviscapine","volume":"15","author":"Chen","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"B13","doi-asserted-by":"publisher","first-page":"113187","DOI":"10.1016\/j.biopha.2022.113187","article-title":"Scutellarin enhances anti-tumor immune responses by reducing TNFR2-expressing CD4+Foxp3+ regulatory T cells","volume":"151","author":"Chen","year":"2022","journal-title":"Biomed. and Pharmacother. = Biomedecine&pharmacotherapie"},{"key":"B14","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41571-022-00639-9","article-title":"Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management","volume":"19","author":"Cooper","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"10940","DOI":"10.1021\/cr500081p","article-title":"Review: a history of cyclodextrins","volume":"114","author":"Crini","year":"2014","journal-title":"Chem. Rev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41419-024-06625-6","article-title":"Scutellarin activates IDH1 to exert antitumor effects in hepatocellular carcinoma progression","volume":"15","author":"Cui","year":"2024","journal-title":"Cell death and Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.biopha.2018.08.127","article-title":"Scutellarin inhibits human renal cancer cell proliferation and migration via upregulation of PTEN","volume":"107","author":"Deng","year":"2018","journal-title":"Biomed. and Pharmacother."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.3390\/ijms21061960","article-title":"The roles of cyclin-dependent kinases in cell-cycle progression and therapeutic strategies in human breast cancer","volume":"21","author":"Ding","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"4681","DOI":"10.1007\/s11033-020-05470-y","article-title":"The critical role of the interplays of EphrinB2\/EphB4 and VEGF in the induction of angiogenesis","volume":"47","author":"Du","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"B20","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.drudis.2021.11.011","article-title":"An updated review of folate-functionalized nanocarriers: a promising ligand in cancer","volume":"27","author":"Ebrahimnejad","year":"2022","journal-title":"Drug Discov. today"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.biopha.2018.06.107","article-title":"Scutellaria: debates on the anticancer property","volume":"105","author":"EghbaliFeriz","year":"2018","journal-title":"Biomed. and Pharmacother."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.21608\/ejchem.2024.332567.10703","article-title":"Cyclodextrin-based compounds and their derived 1, 2, 3-Triazoles: recent aspects, synthesis, overview and applications","author":"El-Sayed","year":"2024","journal-title":"Egypt. J. Chem"},{"key":"B23","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s10337-017-3260-z","article-title":"Study on antitumour activity of scutellarin and its metabolite scutellarein by combining activity screening, target tissue distribution and pharmacokinetics","volume":"80","author":"Feng","year":"2017","journal-title":"Chromatographia"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3390\/cancers3011351","article-title":"Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects","volume":"3","author":"Florea","year":"2011","journal-title":"Cancers"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.3390\/ijms22031025","article-title":"Hedgehog signaling in colorectal cancer: all in the stroma?","volume":"22","author":"Geyer","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.34172\/fnp.2022.03","article-title":"Phytochemical composition profile of Scutellariabornmuelleri methanolic extract using GC-MS analysis","volume":"8","author":"Gharari","year":"2022","journal-title":"Future Nat. Prod."},{"key":"B27","doi-asserted-by":"publisher","first-page":"102925","DOI":"10.1016\/j.bioorg.2019.102925","article-title":"Cisplatin: the first metal based anticancer drug","volume":"88","author":"Ghosh","year":"2019","journal-title":"Bioorg. Chem."},{"key":"B28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2165\/00003495-200059004-00002","article-title":"Clinical perspectives on platinum resistance","volume":"59","author":"Giaccone","year":"2000","journal-title":"Drugs"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/S0140-6736(10)62101-0","article-title":"Non-small-cell lung cancer","volume":"378","author":"Goldstraw","year":"2011","journal-title":"Lancet"},{"key":"B30","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/B978-0-12-398456-2.00032-3","article-title":"Anti-inflammatory and immunomodulatory properties of dietary flavonoids","volume-title":"Polyphenols in human health and disease","author":"Gonz\u00e1lez-Gallego","year":"2014"},{"key":"B31","doi-asserted-by":"publisher","first-page":"15009","DOI":"10.1038\/nrdp.2015.9","article-title":"Non-small-cell lung cancer","volume":"1","author":"Gridelli","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B32","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s11101-017-9505-5","article-title":"Bioactivity, toxicity and detoxification assessment of Dioscorea bulbifera L.: a comprehensive review","volume":"16","author":"Guan","year":"2017","journal-title":"Phytochem. Rev."},{"key":"B33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-030-94753-8_8-1","article-title":"Scutellarin: Bioactivities, pharmacology, and development as promising therapeutic agents and Nutraceuticals","volume-title":"Handbook of Dietary flavonoids","author":"Gunter","year":"2023"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.2174\/1871520617666171016105704","article-title":"Research progress in reversal of tumor multi-drug resistance via natural products","volume":"17","author":"Guo","year":"2017","journal-title":"Anti-Cancer Agents Med. Chem. Former. Curr. Med. Chemistry-Anti-Cancer Agents"},{"key":"B35","doi-asserted-by":"publisher","first-page":"3936","DOI":"10.1002\/ptr.7106","article-title":"Scutellarin ameliorates the stress\u2010induced anxiety\u2010like behaviors in mice by regulating neurotransmitters","volume":"35","author":"Guo","year":"2021","journal-title":"Phytotherapy Res."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202312_34596","article-title":"Molecular docking and network pharmacological analysis of Scutellariabaicalensis against renal cell carcinoma","volume":"27","author":"Guo","year":"2023","journal-title":"Eur. Rev. Med. and Pharmacol. Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ejmech.2017.03.020","article-title":"Scutellarin derivatives as apoptosis inducers: Design, synthesis and biological evaluation","volume":"135","author":"Han","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"B38","doi-asserted-by":"publisher","first-page":"8479","DOI":"10.1111\/jcmm.16809","article-title":"EGR1 promoted anticancer effects of Scutellarin via regulating LINC00857\/miR-150-5p\/c-Myc in osteosarcoma","volume":"25","author":"Han","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e13106","DOI":"10.1111\/sji.13106","article-title":"Immunomodulatory potential of flavonoids for the treatment of autoimmune diseases and tumour","volume":"95","author":"Han","year":"","journal-title":"Scand. J. Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s00044-022-02885-z","article-title":"Design, synthesis of amide derivatives of scutellarin and their antileukemia and neuroprotective activities","volume":"31","author":"Han","year":"","journal-title":"Med. Chem. Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"105207","DOI":"10.1016\/j.fitote.2022.105207","article-title":"Synthesis and biological evaluation of scutellarein derivatives as neuroprotective agents via activating Nrf2\/HO-1 pathway","volume":"160","author":"Han","year":"","journal-title":"Fitoterapia"},{"key":"B42","doi-asserted-by":"publisher","first-page":"23140","DOI":"10.1021\/acsomega.0c02898","article-title":"Extraction of flavonoids from scutellariae radix using ultrasound-assisted deep eutectic solvents and evaluation of their anti-inflammatory activities","volume":"5","author":"Hao","year":"2020","journal-title":"ACS omega"},{"key":"B43","doi-asserted-by":"publisher","first-page":"6821219","DOI":"10.1155\/2019\/6821219","article-title":"C18H17NO6 and its combination with scutellarin suppress the proliferation and induce the apoptosis of human glioma cells via upregulation of FAS\u2010associated factor 1 expression","volume":"2019","author":"He","year":"2019","journal-title":"BioMed Res. Int."},{"key":"B44","doi-asserted-by":"publisher","first-page":"675675","DOI":"10.3389\/fphar.2021.675675","article-title":"Targeting signaling pathway networks in several malignant tumors: progresses and challenges","volume":"12","author":"He","year":"","journal-title":"Front. Pharmacol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1111\/1759-7714.14077","article-title":"Scutellarin improves the radiosensitivity of non-small cell lung cancer cells to iodine-125 seeds via downregulating the AKT\/mTOR pathway","volume":"12","author":"He","year":"","journal-title":"Thorac. cancer"},{"key":"B46","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","article-title":"The biology and management of non-small cell lung cancer","volume":"553","author":"Herbst","year":"2018","journal-title":"Nature"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jare.2018.06.005","article-title":"Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: a review","volume":"15","author":"Hossen","year":"2019","journal-title":"J. Adv. Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"5130","DOI":"10.12659\/msm.904492","article-title":"Scutellarin inhibits proliferation, invasion, and Tumorigenicity in human breast cancer cells by regulating HIPPO-YAP signaling pathway","volume":"23","author":"Hou","year":"2017","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"7617","DOI":"10.1021\/acs.jmedchem.6b01672","article-title":"Nitric oxide donor-based cancer therapy: advances and prospects","volume":"60","author":"Huang","year":"2017","journal-title":"J. Med. Chem."},{"key":"B50","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1021\/acsbiomaterials.2c01247","article-title":"Nitric oxide and tumors: from small-molecule donor to combination therapy","volume":"9","author":"Huang","year":"2022","journal-title":"ACS Biomaterials Sci. and Eng."},{"key":"B51","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/hepr.13259","article-title":"Recent advances in medical management of hepatocellular carcinoma","volume":"49","author":"Ikeda","year":"2019","journal-title":"Hepatology Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.apjtb.2017.10.016","article-title":"Plant-derived anticancer agents: a green anticancer approach","volume":"7","author":"Iqbal","year":"2017","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"B53","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/978-3-030-31269-5_7","article-title":"Skullcaps (Scutellaria spp.): ethnobotany and current research","author":"Irvin","year":"2019","journal-title":"Med. Plants Farm Pharm."},{"key":"B54","doi-asserted-by":"publisher","first-page":"494","DOI":"10.13040\/IJPSR.0975-8232.10(2).494-04","article-title":"Bioactivity of secondary metabolites of various plants: a review","volume":"10","author":"Jain","year":"2019","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"104778","DOI":"10.1016\/j.bse.2023.104778","article-title":"Phytochemical and chemotaxonomic study on Thymus quinquecostatus C\u00ealak","volume":"112","author":"Jia","year":"2024","journal-title":"Biochem. Syst. Ecol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.carres.2013.07.009","article-title":"A novel polyrotaxane-based delivery system for scutellarin: preparation, characterization, and in vitro evaluation","volume":"380","author":"Jiang","year":"2013","journal-title":"Carbohydr. Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e100357","DOI":"10.1371\/journal.pone.0100357","article-title":"Analysis of the transcriptome of Erigeron breviscapus uncovers putative scutellarin and chlorogenic acids biosynthetic genes and genetic markers","volume":"9","author":"Jiang","year":"2014","journal-title":"PLoS One"},{"key":"B58","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1634\/theoncologist.2008-0185","article-title":"Sorafenib for the treatment of unresectable hepatocellular carcinoma","volume":"14","author":"Kane","year":"2009","journal-title":"Oncol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1006\/excr.2000.4838","article-title":"Induction of apoptosis by cancer chemotherapy","volume":"256","author":"Kaufmann","year":"2000","journal-title":"Exp. Cell Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.bbrc.2016.12.114","article-title":"Scutellarin suppresses migration and invasion of human hepatocellular carcinoma by inhibiting the STAT3\/Girdin\/Akt activity","volume":"483","author":"Ke","year":"2017","journal-title":"Biochem. biophysical Res. Commun."},{"key":"B61","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3390\/biom14020200","article-title":"Terpenoid-mediated targeting of STAT3 signaling in cancer: an overview of preclinical studies","volume":"14","author":"Khan","year":"2024","journal-title":"Biomolecules"},{"key":"B62","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/B978-0-323-44942-7.00020-0","article-title":"Cell death pathways: apoptosis and regulated necrosis","volume-title":"Critical care nephrology","author":"Kim-Campbell","year":"2019"},{"key":"B63","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3390\/nu12020457","article-title":"Flavonoids as anticancer agents","volume":"12","author":"Kopustinskiene","year":"2020","journal-title":"Nutrients"},{"key":"B64","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1159\/000449343","article-title":"Hepatocellular carcinoma: therapeutic guidelines and medical treatment","volume":"6","author":"Kudo","year":"2017","journal-title":"Liver cancer"},{"key":"B65","doi-asserted-by":"publisher","first-page":"e2400053","DOI":"10.1002\/ardp.202400053","article-title":"Review on the pharmacological effects and pharmacokinetics of scutellarein","volume":"357","author":"Lai","year":"","journal-title":"Arch. Pharm."},{"key":"B66","doi-asserted-by":"publisher","first-page":"2400053","DOI":"10.1002\/ardp.202400053","article-title":"Review on the pharmacological effects and pharmacokinetics of scutellarein","volume":"357","author":"Lai","year":"","journal-title":"Arch. Pharm."},{"key":"B67","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3109\/10611861003622552","article-title":"Cyclodextrins for drug delivery","volume":"18","author":"Laza-Knoerr","year":"2010","journal-title":"J. drug Target."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.19540\/j.cnki.cjcmm.20200108.401","volume":"45","author":"Lei","year":"2020","journal-title":"Zhongguo Zhong yao za zhi = Zhongguozhongyaozazhi = China J. Chin. materia medica"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10408398.2024.2387320","article-title":"Intestinal absorption mechanism and nutritional synergy promotion strategy of dietary flavonoids: transintestinal epithelial pathway mediated by intestinal transport proteins","author":"Li","year":"2024","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"B70","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.yrtph.2011.02.013","article-title":"Acute and subacute toxicological evaluation of scutellarin in rodents","volume":"60","author":"Li","year":"2011","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"B71","first-page":"817","article-title":"Evaluation on preparation process of brevisapin colon-specific tables and its in vitro release","volume":"38","author":"Li","year":"","journal-title":"Zhongguo Zhong yao za zhi= ZhongguoZhongyaoZazhi= China J. Chin. Materia Medica"},{"key":"B72","doi-asserted-by":"publisher","first-page":"e59473","DOI":"10.1371\/journal.pone.0059473","article-title":"Potentiation of scutellarin on human tongue carcinoma xenograft by low-intensity ultrasound","volume":"8","author":"Li","year":"","journal-title":"PloS one"},{"key":"B73","doi-asserted-by":"publisher","first-page":"172463","DOI":"10.1016\/j.ejphar.2019.172463","article-title":"Scutellarin inhibits the invasive potential of malignant melanoma cells through the suppression epithelial-mesenchymal transition and angiogenesis via the PI3K\/Akt\/mTOR signaling pathway","volume":"858","author":"Li","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"B74","first-page":"212","article-title":"Scutellarin circumvents chemoresistance, promotes apoptosis, and represses tumor growth by HDAC\/miR-34a-mediated down-modulation of Akt\/mTOR and NF-\u03baB-orchestrated signaling pathways in multiple myeloma","volume":"13","author":"Li","year":"2020","journal-title":"Int. J. Clin. Exp. pathology"},{"key":"B75","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1248\/bpb.b20-00822","article-title":"Scutellarin inhibits the growth and EMT of gastric cancer cells through regulating PTEN\/PI3K pathway","volume":"44","author":"Li","year":"2021","journal-title":"Biol. Pharm. Bull."},{"key":"B76","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jconrel.2022.10.012","article-title":"Recent progress in nitric oxide-generating nanomedicine for cancer therapy","volume":"352","author":"Li","year":"2022","journal-title":"J. Control. Release"},{"key":"B77","doi-asserted-by":"publisher","first-page":"123114","DOI":"10.1016\/j.ijpharm.2023.123114","article-title":"Nanodelivery of scutellarin induces immunogenic cell death for treating hepatocellular carcinoma","volume":"642","author":"Li","year":"2023","journal-title":"Int. J. Pharm."},{"key":"B78","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/pat.3477","article-title":"Folic acid\u2010polyamine\u2010\u03b2\u2010cyclodextrin for targeted delivery of scutellarin to cancer cells","volume":"26","author":"Liao","year":"2015","journal-title":"Polym. Adv. Technol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1080\/10717544.2020.1856223","article-title":"Cyclodextrin pendant polymer as an efficient drug carrier for scutellarin","volume":"27","author":"Liao","year":"2020","journal-title":"Drug Deliv."},{"key":"B80","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.1111\/jcmm.14169","article-title":"Scutellarin inhibits proliferation and invasion of hepatocellular carcinoma cells via down\u2010regulation of JAK2\/STAT3 pathway","volume":"23","author":"Liu","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"B81","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ctrv.2008.09.005","article-title":"New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin","volume":"35","author":"Li-Weber","year":"2009","journal-title":"Cancer Treat. Rev."},{"key":"B82","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","article-title":"Immunotherapies for hepatocellular carcinoma","volume":"19","author":"Llovet","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.3390\/cancers11081076","article-title":"PTEN tumor-suppressor: the dam of stemness in cancer","volume":"11","author":"Luongo","year":"2019","journal-title":"Cancers"},{"key":"B84","doi-asserted-by":"publisher","first-page":"23169","DOI":"10.1002\/jcp.28883","article-title":"Scutellarin inhibits hypoxia\u2010induced epithelial\u2010mesenchymal transition in bladder cancer cells","volume":"234","author":"Lv","year":"2019","journal-title":"J. Cell. physiology"},{"key":"B85","doi-asserted-by":"publisher","first-page":"7733","DOI":"10.3390\/molecules28237733","article-title":"Sonosensitive cavitation Nuclei\u2014a Customisable Platform technology for enhanced therapeutic delivery","volume":"28","author":"Lyons","year":"2023","journal-title":"Molecules"},{"key":"B86","doi-asserted-by":"publisher","first-page":"105071","DOI":"10.1016\/j.jddst.2023.105071","article-title":"A novel approach of modeling pharmacokinetics and pharmacokinetics-pharmacodynamics for the intravenous nano drug delivery system","volume":"89","author":"Ma","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"155418","DOI":"10.1016\/j.phymed.2024.155418","article-title":"Scutellarin, a flavonoid compound from Scutellariabarbata, suppresses growth of breast cancer stem cells in vitro and in tumor-bearing mice","volume":"128","author":"Ma","year":"2024","journal-title":"Phytomedicine"},{"key":"B88","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1016\/s0962-8924(01)02124-9","article-title":"Apoptosis and cancer chemotherapy","volume":"11","author":"Makin","year":"2001","journal-title":"Trends Cell Biol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1146\/annurev-physiol-020518-114700","article-title":"Normalizing function of tumor vessels: progress, opportunities, and challenges","volume":"81","author":"Martin","year":"2019","journal-title":"Annu. Rev. physiology"},{"key":"B90","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1038\/s41401-022-00873-y","article-title":"Scutellarin suppresses triple-negative breast cancer metastasis by inhibiting TNF\u03b1-induced vascular endothelial barrier breakdown","volume":"43","author":"Mei","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"B91","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fonc.2015.00024","article-title":"PTEN: multiple functions in human malignant tumors","volume":"5","author":"Milella","year":"2015","journal-title":"Front. Oncol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.1021\/acs.biomac.4c00685","article-title":"Recent advancements in polymeric N-nitrosamine-based nitric oxide (NO) donors and their therapeutic applications","volume":"25","author":"Mondal","year":"2024","journal-title":"Biomacromolecules"},{"key":"B93","doi-asserted-by":"publisher","first-page":"640","DOI":"10.2174\/1871520620666200811112156","article-title":"Scutellarin suppresses RPMI7951 melanoma cell proliferation by targeting TOPK","volume":"21","author":"Mu","year":"2021","journal-title":"Anti-cancer agents Med. Chem."},{"key":"B94","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/ddr.21545","article-title":"Folic acid functionalized nanoparticles as pharmaceutical carriers in drug delivery systems","volume":"80","author":"Narmani","year":"2019","journal-title":"Drug Dev. Res."},{"key":"B95","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3390\/molecules23020310","article-title":"Synthesis of scutellarein derivatives with a long aliphatic chain and their biological evaluation against human cancer cells","volume":"23","author":"Ni","year":"2018","journal-title":"Molecules"},{"key":"B96","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jep.2015.02.031","article-title":"Scutellarin protects against the liver injury induced by diosbulbin B in mice and its mechanism","volume":"164","author":"Niu","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"105","DOI":"10.34172\/ijep.2022.5503","article-title":"Anti-cancer and anti-bacterial effects of bioactive compounds of scutellaria species","volume":"10","author":"Nourizadeh","year":"2022","journal-title":"Int. J. Enteric Pathogens"},{"key":"B98","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3390\/ph15030335","article-title":"Revolutionization in cancer therapeutics via targeting major immune checkpoints PD-1, PD-L1 and CTLA-4","volume":"15","author":"Pandey","year":"2022","journal-title":"Pharmaceuticals"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1399677","DOI":"10.3389\/fphar.2024.1399677","article-title":"Ferroptosis targeting natural compounds as a promising approach for developing potent liver cancer agents","volume":"15","author":"Pandey","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.3390\/ijms24033015","article-title":"The EPH\/ephrin system in Pancreatic Ductal Adenocarcinoma (PDAC): from pathogenesis to treatment","volume":"24","author":"Papadakos","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B101","doi-asserted-by":"publisher","first-page":"16932","DOI":"10.1021\/acs.jmedchem.4c01038","article-title":"Multifunctional molecular hybrids Photoreleasing nitric oxide: advantages, Pitfalls, and opportunities","volume":"67","author":"Parisi","year":"2024","journal-title":"J. Med. Chem."},{"key":"B102","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1007\/s10311-021-01244-5","article-title":"History of cyclodextrin-based polymers in food and pharmacy: a review","volume":"19","author":"Petitjean","year":"2021","journal-title":"Environ. Chem. Lett."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/polysaccharides3010001","article-title":"Cyclodextrins: Structural, chemical, and physical properties, and applications","volume":"3","author":"Poulson","year":"2021","journal-title":"Polysaccharides"},{"key":"B104","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10847-017-0752-2","article-title":"Application of cyclodextrins in cancer treatment","volume":"89","author":"Qiu","year":"2017","journal-title":"J. inclusion Phenom. Macrocycl. Chem."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.2174\/1871520618666180604085612","article-title":"An overview of natural plant products in the treatment of hepatocellular carcinoma","volume":"18","author":"Rawat","year":"2018","journal-title":"Anti-Cancer Agents Med. Chem. Former. Curr. Med. Chemistry-Anti-Cancer Agents"},{"key":"B106","doi-asserted-by":"publisher","first-page":"115323","DOI":"10.1016\/j.bcp.2022.115323","article-title":"Cisplatin in cancer treatment","volume":"206","author":"Romani","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"5445291","DOI":"10.1155\/2022\/5445291","article-title":"Flavonoids a bioactive compound from medicinal plants and its therapeutic applications","volume":"2022","author":"Roy","year":"2022","journal-title":"BioMed Res. Int."},{"key":"B108","doi-asserted-by":"publisher","first-page":"113198","DOI":"10.1016\/j.jep.2020.113198","article-title":"Traditional uses, ten-years research progress on phytochemistry and pharmacology, and clinical studies of the genus Scutellaria","volume":"265","author":"Shen","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3892\/ijmm.2014.1997","article-title":"Scutellarein inhibits cancer cell metastasis in vitro and attenuates the development of fibrosarcoma in vivo","volume":"35","author":"Shi","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"B110","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13020-020-00384-0","article-title":"Applications, phytochemistry, pharmacological effects, pharmacokinetics, toxicity of Scutellariabaicalensis Georgi. and its probably potential therapeutic effects on COVID-19: a review","volume":"15","author":"Song","year":"2020","journal-title":"Chin. Med."},{"key":"B111","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3389\/fphar.2018.00092","article-title":"Scutellarin increases cisplatin-induced apoptosis and autophagy to overcome cisplatin resistance in non-small cell lung cancer via ERK\/p53 and c-met\/AKT signaling pathways","volume":"9","author":"Sun","year":"","journal-title":"Front. Pharmacol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.7150\/jca.25921","article-title":"Scutellarin induces apoptosis and autophagy in NSCLC cells through ERK1\/2 and AKT Signaling Pathways in vitro and in vivo","volume":"9","author":"Sun","year":"","journal-title":"J. Cancer"},{"key":"B113","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.omto.2021.03.010","article-title":"Scutellarin resensitizes oxaliplatin-resistant colorectal cancer cells to oxaliplatin treatment through inhibition of PKM2","volume":"21","author":"Sun","year":"2021","journal-title":"Mol. Therapy-Oncolytics"},{"key":"B114","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.3390\/molecules29174134","article-title":"Chemical constituents, anti-tumor mechanisms, and clinical application: a comprehensive review on Scutellariabarbata","volume":"29","author":"Sun","year":"2024","journal-title":"Molecules"},{"key":"B115","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13046-023-02747-5","article-title":"The Ephrin tyrosine kinase a3 (EphA3) is a novel mediator of RAGE-prompted motility of breast cancer cells","volume":"42","author":"Talia","year":"2023","journal-title":"J. Exp. and Clin. Cancer Res."},{"key":"B116","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.3390\/biomedicines9101353","article-title":"Targeting drug chemo-resistance in cancer using natural products","volume":"9","author":"Talib","year":"2021","journal-title":"Biomedicines"},{"key":"B117","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2147\/OTT.S187426","article-title":"Scutellarin inhibits the metastasis and cisplatin resistance in glioma cells","volume":"12","author":"Tang","year":"2019","journal-title":"OncoTargets Ther."},{"key":"B118","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/medsci8010018","article-title":"Breast cancer: a molecularly heterogenous disease needing subtype-specific treatments","volume":"8","author":"Testa","year":"2020","journal-title":"Med. Sci."},{"key":"B119","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1159\/000489331","article-title":"AGO recommendations for the diagnosis and treatment of patients with advanced and metastatic breast cancer: update 2018","volume":"13","author":"Thill","year":"2018","journal-title":"Breast Care"},{"key":"B120","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1248\/bpb.b15-00511","article-title":"Delineation of platelet activation pathway of scutellarein revealed its intracellular target as protein kinase C","volume":"39","author":"Tian","year":"2016","journal-title":"Biol. Pharm. Bull."},{"key":"B121","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.freeradbiomed.2012.04.025","article-title":"Tumor growth inhibition by sonodynamic therapy using a novel sonosensitizer","volume":"53","author":"Tsuru","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"B122","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.pbiomolbio.2023.04.006","article-title":"From traditional medicine to modern oncology: scutellarin, a promising natural compound in cancer treatment","volume":"180","author":"Vesaghhamedani","year":"2023","journal-title":"Prog. Biophysics Mol. Biol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.pharmthera.2018.05.006","article-title":"Clinical benefits and pharmacology of scutellarin: a comprehensive review","volume":"190","author":"Wang","year":"2018","journal-title":"Pharmacol. and Ther."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1080\/10717544.2021.1960928","article-title":"Triglyceride-mimetic prodrugs of scutellarin enhance oral bioavailability by promoting intestinal lymphatic transport and avoiding first-pass metabolism","volume":"28","author":"Wang","year":"","journal-title":"Drug Deliv."},{"key":"B125","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12645-021-00102-x","article-title":"Preparation of nanoparticles of \u03b2-cyclodextrin-loaded scutellarein anti-tumor activity research by targeting integrin \u03b1 v \u03b23","volume":"12","author":"Wang","year":"","journal-title":"Cancer Nanotechnol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1111\/jcmm.17788","article-title":"Scutellarin inhibits the glioma cell proliferation by downregulating BIRC5 to promote cell apoptosis","volume":"27","author":"Wang","year":"2023","journal-title":"J. Cell. Mol. Med."},{"key":"B127","doi-asserted-by":"publisher","first-page":"6811","DOI":"10.1021\/jm100509v","article-title":"Folate-targeted therapies for cancer","volume":"53","author":"Xia","year":"2010","journal-title":"J. Med. Chem."},{"key":"B128","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s11094-017-1606-3","article-title":"Ultrasonic-microwave assisted extraction of total flavonoids from scutellaria baicalensis using response surface methodology","volume":"51","author":"Xiang","year":"2017","journal-title":"Pharm. Chem. J."},{"key":"B129","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ejps.2016.08.054","article-title":"A new mechanism for increasing the oral bioavailability of scutellarin with Cremophor EL: activation of MRP3 with concurrent inhibition of MRP2 and BCRP","volume":"93","author":"Xiao","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"B130","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejphar.2018.11.040","article-title":"Scutellarin synergistically enhances cisplatin effect against ovarian cancer cells through enhancing the ability of cisplatin binding to DNA","volume":"844","author":"Xie","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s13659-024-00441-3","article-title":"Current advances on the therapeutic potential of scutellarin: an updated review","volume":"14","author":"Xie","year":"2024","journal-title":"Nat. Prod. Bioprospecting"},{"key":"B132","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/aps.2011.11","article-title":"Metabolic and pharmacokinetic studies of scutellarin in rat plasma, urine, and feces","volume":"32","author":"Xing","year":"","journal-title":"Acta Pharmacol. Sin."},{"key":"B133","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/aps.2011.11","article-title":"Metabolic and pharmacokinetic studies of scutellarin in rat plasma, urine, and feces","volume":"32","author":"Xing","year":"","journal-title":"Acta Pharmacol. Sin."},{"key":"B134","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/aps.2011.11","article-title":"Metabolic and pharmacokinetic studies of scutellarin in rat plasma, urine, and feces","volume":"32","author":"Xing","year":"","journal-title":"Acta Pharmacol. Sin."},{"key":"B135","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13020-020-00307-z","article-title":"Anti-colorectal cancer effects of scutellarin revealed by genomic and proteomic analysis","volume":"15","author":"Xiong","year":"2020","journal-title":"Chin. Med."},{"key":"B136","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1002\/ptr.4892","article-title":"Scutellarin\u2010induced apoptosis in HepG2 hepatocellular carcinoma cells via a STAT3 pathway","volume":"27","author":"Xu","year":"2013","journal-title":"Phytotherapy Res."},{"key":"B137","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejps.2015.11.008","article-title":"Characterization and evaluation of a folic acid receptor-targeted cyclodextrin complex as an anticancer drug delivery system","volume":"83","author":"Xu","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"B138","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.canlet.2016.05.012","article-title":"Role of the tumor microenvironment in regulating apoptosis and cancer progression","volume":"378","author":"Yaacoub","year":"2016","journal-title":"Cancer Lett."},{"key":"B139","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.foodchem.2017.12.086","article-title":"Development and characterization of a green procedure for apigenin extraction from Scutellaria barbata D. Don","volume":"252","author":"Yang","year":"2018","journal-title":"Food Chem."},{"key":"B140","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.carbpol.2012.10.012","article-title":"Scutellarin-cyclodextrin conjugates: synthesis, characterization and anticancer activity","volume":"92","author":"Yang","year":"2013","journal-title":"Carbohydr. Polym."},{"key":"B141","doi-asserted-by":"publisher","first-page":"929","DOI":"10.3892\/mmr.2016.6081","article-title":"Scutellarin suppresses growth and causes apoptosis of human colorectal cancer cells by regulating the p53 pathway","volume":"15","author":"Yang","year":"","journal-title":"Mol. Med. Rep."},{"key":"B142","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.bbadis.2016.11.024","article-title":"Differential regulation of baicalin and scutellarin on AMPK and Akt in promoting adipose cell glucose disposal","volume":"1863","author":"Yang","year":"","journal-title":"Biochimica Biophysica Acta (BBA)-Molecular Basis Dis."},{"key":"B143","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3389\/fimmu.2018.00784","article-title":"Role of TNF\u2013TNF receptor 2 signal in regulatory T cells and its therapeutic implications","volume":"9","author":"Yang","year":"2018","journal-title":"Front. Immunol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.fbp.2019.09.004","article-title":"Separation and quantification of bioactive flavonoids from Scutellaria barbata using a green procedure","volume":"118","author":"Yang","year":"","journal-title":"Food Bioprod. Process."},{"key":"B145","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jcou.2019.04.008","article-title":"Kinetics and mass transfer considerations for an ultrasound-assisted supercritical CO2 procedure to produce extracts enriched in flavonoids from Scutellaria barbata","volume":"32","author":"Yang","year":"","journal-title":"J. CO2 Util."},{"key":"B146","first-page":"103","article-title":"TNFR2: role in cancer immunology and immunotherapy","volume-title":"ImmunoTargets Ther","author":"Yang","year":"2021"},{"key":"B147","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/or.2022.8293","article-title":"Molecular mechanisms of platinum based chemotherapy resistance in ovarian cancer","volume":"47","author":"Yang","year":"2022","journal-title":"Oncol. Rep."},{"key":"B148","doi-asserted-by":"publisher","first-page":"132134","DOI":"10.1016\/j.ijbiomac.2024.132134","article-title":"Scutellarin-loaded pH\/H2O2 dual-responsive polymer cyclodextrin mesoporous silicon framework nanocarriers for enhanced cancer therapy","volume":"269","author":"Yi","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"5404","DOI":"10.1016\/j.bmcl.2017.11.011","article-title":"Scutellarin inhibits Hela cell growth and glycolysis by inhibiting the activity of pyruvate kinase M2","volume":"27","author":"You","year":"2017","journal-title":"Bioorg. and Med. Chem. Lett."},{"key":"B150","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/B978-0-323-46143-6.00014-2","article-title":"Polymer-based nanocarriers for therapeutic nucleic acids delivery","volume-title":"Nanostructures for drug delivery","author":"Yuan","year":"2017"},{"key":"B151","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1039\/d2mo00220e","article-title":"Focus on the molecular mechanisms of cisplatin resistance based on multi-omics approaches","volume":"19","author":"Yue","year":"2023","journal-title":"Mol. Omics"},{"key":"B152","doi-asserted-by":"publisher","first-page":"174253","DOI":"10.1016\/j.ejphar.2021.174253","article-title":"Scutellarin ameliorates colitis-associated colorectal cancer by suppressing Wnt\/\u03b2-catenin signaling cascade","volume":"906","author":"Zeng","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"153972","DOI":"10.1016\/j.phymed.2022.153972","article-title":"Suppression of colitis-associated colorectal cancer by scutellarin through inhibiting Hedgehog signaling pathway activity","volume":"98","author":"Zeng","year":"2022","journal-title":"Phytomedicine"},{"key":"B154","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1007\/s11095-024-03790-3","article-title":"An update on recent drug delivery systems targeting brain diseases via the transnasal pathway","volume":"41","author":"Zeng","year":"2024","journal-title":"Pharm. Res."},{"key":"B155","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1515\/biol-2021-0085","article-title":"Scutellarin-induced A549 cell apoptosis depends on activation of the transforming growth factor-\u03b21\/smad2\/ROS\/caspase-3 pathway","volume":"16","author":"Zhang","year":"2021","journal-title":"Open life Sci."},{"key":"B156","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12943-022-01616-7","article-title":"Wnt signaling in colorectal cancer: pathogenic role and therapeutic target","volume":"21","author":"Zhao","year":"2022","journal-title":"Mol. cancer"},{"key":"B157","doi-asserted-by":"publisher","first-page":"1463140","DOI":"10.3389\/fphar.2024.1463140","article-title":"Pharmacological effects and the related mechanism of scutellarin on inflammation-related diseases: a review","volume":"15","author":"Zhou","year":"","journal-title":"Front. Pharmacol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"1463140","DOI":"10.3389\/fphar.2024.1463140","article-title":"Pharmacological effects and the related mechanism of scutellarin on inflammation-related diseases: a review","volume":"15","author":"Zhou","year":"","journal-title":"Front. Pharmacol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3390\/cells12030447","article-title":"Advances of Wnt signalling pathway in colorectal cancer","volume":"12","author":"Zhu","year":"2023","journal-title":"Cells"},{"key":"B160","first-page":"5094","article-title":"Scutellarin suppresses human colorectal cancer metastasis and angiogenesis by targeting ephrinb2","volume":"9","author":"Zhu","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"B161","doi-asserted-by":"publisher","first-page":"116589","DOI":"10.1016\/j.jep.2023.116589","article-title":"Pharmacokinetic-pharmacodynamic (PK\/PD) modeling to study the hepatoprotective effect of Perilla Folium on the acute hepatic injury rats","volume":"313","author":"Zhu","year":"2023","journal-title":"J. Ethnopharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1579609\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T18:01:45Z","timestamp":1743098505000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1579609\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":161,"alternative-id":["10.3389\/fphar.2025.1579609"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1579609","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,27]]},"article-number":"1579609"}}